Sleep disorders (combined)

SLEEP

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

44299

diagram downward connector
SLEEP

Control definitions

Control exclude F5_BEHAVE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 44299 19034 25265
Unadjusted prevalence (%) 11.75 9.03 15.19
Mean age at first event (years) 54.66 54.02 55.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.55 [1.33, 1.80] 9.9e-9 2354
15 years 0.01 1.03 [0.90, 1.18] 6.4e-1 1016
5 years 0.00 2.20 [1.94, 2.49] 2.4e-35 637
1 year 0.00 4.11 [3.46, 4.87] 2.3e-59 231

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: SLEEP – Sleep disorders (combined)
GWS hits: 17

Survival analyses between endpoints

↥

Plot

before Sleep disorders (combined)
after Sleep disorders (combined)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Sleep disorders (combined)

↥

Endpoint not on priority list, no data to show.